Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice. (October 2017)
- Record Type:
- Journal Article
- Title:
- Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice. (October 2017)
- Main Title:
- Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice
- Authors:
- Inokuchi, Haruo
Mizowaki, Takashi
Norihisa, Yoshiki
Takayama, Kenji
Ikeda, Itaru
Nakamura, Kiyonao
Hiraoka, Masahiro - Abstract:
- Highlights: High-dose prostate IMRT was well tolerated in terms of long-term GU toxicities. Hematuria was the most common long-term GU toxicity after high-dose IMRT. Bladder neck dose–volume data were significantly associated with hematuria. Abstract: Purpose: To investigate the factors associated with the risk of long-term genitourinary (GU) toxicity among high-risk prostate cancer (PC) patients treated with high-dose intensity-modulated radiotherapy (IMRT). Methods and materials: Between 2000 and 2011, PC patients treated with 78 Gy in 39 fractions delivered by IMRT combined with neo-adjuvant hormonal therapy were selected from among our database. GU toxicities and clinical factors, as well as separate anatomical urinary structures, were evaluated in terms of their associations. Results: A total of 309 patients was included in this study. The median follow-up was 104 months (range: 24–143 months). The most frequently observed late grade ≥2 GU toxicity was hematuria (11.2%: 10-year actuarial risk) with radiation cystitis observed in the majority of patients. In univariate analysis, late grade ≥2 hematuria was associated with the exposure to doses >75 Gy (V75) of the bladder neck and V70 of the bladder wall, as well as with T stage. V75 of the bladder neck remained significant in multivariate analysis ( p = 0.049). Conclusions: At the 10-year follow up of high-dose IMRT, a major concern was proved to be delayed cystitis related to the higher volume of bladder neck doseHighlights: High-dose prostate IMRT was well tolerated in terms of long-term GU toxicities. Hematuria was the most common long-term GU toxicity after high-dose IMRT. Bladder neck dose–volume data were significantly associated with hematuria. Abstract: Purpose: To investigate the factors associated with the risk of long-term genitourinary (GU) toxicity among high-risk prostate cancer (PC) patients treated with high-dose intensity-modulated radiotherapy (IMRT). Methods and materials: Between 2000 and 2011, PC patients treated with 78 Gy in 39 fractions delivered by IMRT combined with neo-adjuvant hormonal therapy were selected from among our database. GU toxicities and clinical factors, as well as separate anatomical urinary structures, were evaluated in terms of their associations. Results: A total of 309 patients was included in this study. The median follow-up was 104 months (range: 24–143 months). The most frequently observed late grade ≥2 GU toxicity was hematuria (11.2%: 10-year actuarial risk) with radiation cystitis observed in the majority of patients. In univariate analysis, late grade ≥2 hematuria was associated with the exposure to doses >75 Gy (V75) of the bladder neck and V70 of the bladder wall, as well as with T stage. V75 of the bladder neck remained significant in multivariate analysis ( p = 0.049). Conclusions: At the 10-year follow up of high-dose IMRT, a major concern was proved to be delayed cystitis related to the higher volume of bladder neck dose exposed excess over 75 Gy. … (more)
- Is Part Of:
- Clinical and translational radiation oncology. Volume 6(2017)
- Journal:
- Clinical and translational radiation oncology
- Issue:
- Volume 6(2017)
- Issue Display:
- Volume 6, Issue 2017 (2017)
- Year:
- 2017
- Volume:
- 6
- Issue:
- 2017
- Issue Sort Value:
- 2017-0006-2017-0000
- Page Start:
- 31
- Page End:
- 36
- Publication Date:
- 2017-10
- Subjects:
- Intensity-modulated radiation therapy -- Prostate cancer -- GU toxicity -- Long term follow-up -- Urinary dose
Cancer -- Radiotherapy -- Periodicals
Oncology -- Periodicals
Cancer -- Radiotherapy
Oncology
Radiation Oncology
Neoplasms -- radiotherapy
Translational Medical Research
Periodicals
Electronic journals
Periodicals
616.9940642 - Journal URLs:
- https://www.journals.elsevier.com/clinical-and-translational-radiation-oncology ↗
http://www.sciencedirect.com/science/journal/24056308 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.ctro.2017.09.005 ↗
- Languages:
- English
- ISSNs:
- 2405-6308
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4775.xml